Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-10-16
1998-06-23
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514466, 514471, 514506, 514563, 548495, 549441, 549450, 560 42, 562448, A61K 31405, C07D20918
Patent
active
057706204
ABSTRACT:
The present invention provides novel protein tyrosine phosphatase modulating compounds having an aryl acrylic acid structure, compositions comprising the compounds, and methods of making and using the same.
REFERENCES:
patent: 4920131 (1990-04-01), Huang et al.
patent: 5017610 (1991-05-01), Imaki et al.
patent: 5025006 (1991-06-01), DiNinno et al.
patent: 5132422 (1992-07-01), DiNinno et al.
patent: 5157033 (1992-10-01), DiNinno et al.
patent: 5206392 (1993-04-01), Dean
patent: 5208229 (1993-05-01), Schmitt
patent: 5208328 (1993-05-01), DiNinno et al.
patent: 5214139 (1993-05-01), DiNinno et al.
patent: 5336681 (1994-08-01), Imaki et al.
Abbas, et al. "Cellular and Molecular Immunology" (1991) pp. 99-104 W.B. Saunders Co., Phila. PA.
Chernoff et al. "Cloning of a cDNA for a major human protein-tyrosine-phosphatase" Proc. Natl. Acad. Sci. USA vol. 87 pp. 2735-2739, Apr. 1990.
Bliska et al. "Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulenc determinant" Proc. Natl. Acad. Sci. USA vol. 88, pp. 1187-1191, Feb. 1991.
Fischer et al. "Protein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane Enzymes" Science vol. 253, pp. 401-406 26 Jul. 1991.
Flint, et al. "Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation" The EMBO Journal vol. 12, pp. 1937-1946, 1993.
Ghosh et al. "Suramin, an Experimental Chemotherapuetic Drug, Irreversibly Blocks T Cell CD45-Protein Tyrosine Phosphatase In Vitro" Biochemical and Biophyiscal Research Communications vol. 194, No. 1, 1993 Jul., pp. 36-44.
Hunter et al. "Protein-Tyrosine Kinases" Ann. Rev. Biochem. pp. 897-930 (1985) vol. 54.
Klarlund et al. "Transformation of Cells by an Inhibitor of Phosphatases Acting on Phosphotyrosine in Proteins" Danish Cancer Society (1984) pp. 707-717.
Knorr et al. "New Coupling Reagents in Peptide Chemistry" Tetrahedron Letters, vol. 30, No. 15, pp. 1927-1930 (1989).
MacKintosh et al. "Inhibitors of Protein Kinases and Phosphatases" TIBS 19-Nov. 1994 pp. 444-448.
Kishihara et al. "Normal B Lymphocyte Development but Impaired T Cell Maturation in CD45-Exon6 Protein Tyrosine Phosphatase-Deficient Mice" Cell vol. 74, pp. 143-156 Jul. 16, 1993.
Posner et al. "Peroxovanadium Compounds" Journal of Biological Chemistry, vol. 269, No. 6 pp. 4596-4604 Feb. 1994.
Trowbridge et al. "CD45: An Emerging Role as a Protein Tyrosine Phosphatase Required for Lymphocyte Activation and Development" Annu. Rev. Immunol, 1994 12:85-116.
Ugi et al. "Multicomponent reations in organic chemistry" Endeavour, New Series, vol. 18, No. 3, 1994 (No page #s).
Levitzki et al. "Tyrosine Kinase Inhibition: An Approach to Drug Development" Science vol. 267 Mar. 24, 1995.
Tonks et al. "Purification of the Major Protein-tyrosine-phosphatases of Human Placenta" The Journal of Biological Chemistry vol. 263, No. 14 pp. 6722-6730 May, 1988.
Zanke et al. "Cloning and expression of an inducible lymphoid-specific, protein tyrosine phosphatase (HePTPase)" Eur. J. Imm. 1992, 22:235-239.
Wiener et al. "Overexpression of the Protein Tyrosine Phosphatase PTP1B in Human Breast Cancer: Association With Protein Expression" Journal of the Nat'l Cancer Inst., vol. 86, No. 5 (1994) pp. 372-378.
Imbert et al. "Induction of tyrosine phosphorylation and T-cell activation by vanadate perozide, an inhibitor of protein tryosine phosphatases" Biochem J. (1994) vol. 297 pp. 163-173.
Hoppe et al. "Expression, purification and crystallization of human phophotyrosine phosphatase 1B" Eur. J. Biochem. 223, 1069-1077 (1994).
Barford et al. "Crystal Struture of Human Protein Tyrosine Phosphatase 1B" Science, vol. 263, Mar. 11, 1994 pp. 1397-1404.
Burke et al. "Potent Inhibition of Insulin Receptor Dephosphorylation By a Hexamer Peptide Containing the Phosphotyrosyl Mimetic F.sub.2 Pmp" Biochemical and Biophysical Research Communications vol. 24, No. 1(1994) pp. 129-134.
Shenolikar et al. "Protein Serine/Threonine Phosphatases" Annu. Rev. Cell Biol. 1994, 10:55-86.
Sun et al. "Inhibition of Ras-Induced DNA Synthesis by Expression of the Phosphatase MKP-1" Science, vol. 266, Oct. 14, 1994 pp. 285-288.
Marshall, C.J. "Specificity of Receptor Tyrosine Kinase Signaling: Transient versus Sustained Extracellular Signal-Regulated Kinase Activation" Cell vol. 80, 179-185 Jan. 27, 1995.
Hunter "Protein Kinases and Phosphatases: The Yin and Yang of Protein Phosphorylation and Signaling" Cell, vol. 80, 225-236, Jan. 27, 1995.
Rink "Solid-Phase Synthesis of Protected Peptide Fragments using a Trialkoxy-Diphenyl-Methylester Resin" Tetrahedron Letters, vol. 28, No. 33, pp. 3787-3790, 1987.
Barford et al. "Purification and Crystallization of the Catalytic Domain of Human Protein Tyrosine Phosphatase 1B Expressed in Escherichia coli" J. Mol. Biol. (1994) vol. 239, pp. 726-730.
Inoue et al. "Fungal Metabolites Part II" Journal of Antibiotics Feb. 1994, vol. 47 No. 2, pp. 208-214.
Burke et al. "Nonhydrolyzable Phosphotyrosyl Mimetics for the Preparation of Phosphatase-Resistan SH2 Domain Inhibitors" Biochemistry 1994, 33, pp. 6490-6494.
Li, W. et al. "A New Function for a Phosphotyrosine Phosphatase: Linking GRB2-SOs to a Receptor Tyrosine Kinase" Molecular and Cellular Biology, Jan. '94 pp. 509-517.
Berger et al. "Leukocyte Common Antigen (CD45) is Required for Immunoglobulin E-mediated Degranulation of Mast Cells" J. Exp. Med., vol. 180 Aug. 1994 pp. 471-476.
Cicirelli, et al. "Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes" Proc. Natl. Acad. Sci. USA vol. 87, pp. 5514-5518, Jul. 1990.
Charbonneau et al. "Human placenta protein-tyrosine-phosphatase: Amino acid sequence and relationship to a family of receptor-like proteins" Proc. Natl. Acad. Sci. USA, vol. 86, pp. 5252-5256, Jul. 1989.
Bollen et al. "The Structure, Role, and Regulation of Type 1 Protein Phosphatases" Critical Reviews in Biochemistry and Molecular Biology, 27(3):227-281 (1992).
Cohen "Signal integration at the level of protein kinases, protein phosphatases and their substrates" TIBS 17, Oct. 1992 pp. 408-413.
Wiener, et al. "Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas" Am. J. Obstet Gynecol vol. 170, No. 4 pp. 117-1183 (1994).
Cao, X. et al., Bioorganic & Medicinal Chemistry Letters, vol. 5, No. 24, pp. 2953-2958, (1995).
Arena, G. et al., J. Chem. Soc. Perkin 2, (1993), (10) pp. 1941-1945.
Crump, R.A.N.C. et al, J. Chem. Soc. Perkin 1, (1992) (24) pp. 3277-3294.
Cao Xiaodong
Mjalli Adnan M. M.
Moran Edmund J.
Chow Frank S.
Ontogen Corporation
Richter Johann
LandOfFree
Aryl acrylic acid derivatives useful as protein tyrosine phospha does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl acrylic acid derivatives useful as protein tyrosine phospha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl acrylic acid derivatives useful as protein tyrosine phospha will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1395135